Openbookopenbook
Equity
Merck KGaA ADR(MKKGY)
USD --+0.00%
Reward44Moderate
Risk29Low
📊75%Data
7.4% dividend yield
MKKGY
+0.0 · +0.00%
USD · PINK
Merck KGaA ADR | Healthcare
Defensive Anchor
Market Cap:65.00Bn
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
29
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MKKGY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: €34.04.

What is Merck KGaA ADR?

Merck KGaA operates as a science and technology company in Germany and internationally.

MKKGY · Verdict

Moderate reward · low risk

MKKGY stands out on cash flow and profitability, but watch the growth signal.

Based on 88% data coverage

MKKGY · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow82/100

    11% free-cash-flow margin

  • Profitability68/100

    13% net margin · 10% ROE

  • Volatility65/100

    Above average

Watchouts 1

  • Growth24/100

    Rev +2.4% CAGR · earnings -3.1%

Model-based scoring. For information only — not financial advice.

What is Merck KGaA ADR?

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 65.00B, and a P/E ratio of 18.7x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap65.00B
P/E Ratio18.6875
Dividend Yield7.41%
52 Week High31
52 Week Low23.8929
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding646M
No. of Employees62,346
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.73
CurrencyUSD · Reports in EUR
Websitewww.emdgroup.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.